Research output per year
Research output per year
Personal profile
Academic discipline
MEDS-21/A - Obstetrics and Gynaecology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Claudia Marchetti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country level (based on research outputs with Scopus ID). Dive into details by clicking on the dots.
-
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study
Marchetti, C., Fagotti, A., Fruscio, R., Cassani, C., Incorvaia, L., Perri, M. T., Sassu, C. M., Camnasio, C. A., Giudice, E., Minucci, A., Seca, M., Arbustini, E., Vertechy, L., De Bonis, M., Boccia, S. M., Giannarelli, D., Salutari, V., Distefano, M., Ferrandina, M. G. & Nero, C. & 4 others, , 2025, In: ESMO Open. 10, 4, p. 1-7 7 p.Research output: Contribution to journal › Article
-
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery
Marchetti, C., Ergasti, R., Capomacchia, F. M., Giannarelli, D., Mastrantoni, L., Pepe, F., Apostol, A. I., Sassu, C. M., Nero, C., Piermattei, A., Zannoni, G. F., Troncone, G., Colomban, O., Russo, G., Carrot, A., Malapelle, U., You, B., Lorusso, D., Scambia, G. & Fagotti, A., 2025, In: Gynecologic Oncology. 195, X, p. 16-25 10 p.Research output: Contribution to journal › Article
-
Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence
Loverro, M., Marchetti, C., Salutari, V., Giannarelli, D., Vertechy, L., Capomacchia, F. M., Caricato, C., Campitelli, M., Panico, C., Avesani, G., Cocciolillo, F., Rosati, A., Scambia, G. & Fagotti, A., 2025, In: ESMO Open. 10, 2, p. 1-8 8 p.Research output: Contribution to journal › Article
-
Value of frozen section to tailor surgical staging in apparent early-stage epithelial ovarian cancer
Di Berardino, S., Bizzarri, N., Ciancia, M., Moro, F., Padial Urtueta, B., Marchetti, C., Zannoni, G. F., Scambia, G. & Fagotti, A., 2025, In: International Journal of Gynecological Cancer. Feb, p. 1-8 8 p.Research output: Contribution to journal › Article
-
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status
Marchetti, C., Ataseven, B., Perrone, A. M., Cassani, C., Fruscio, R., Sassu, C. M., Apostol, A. I., Harter, P., De Iaco, P., Camnasio, C. A., Moubarak, M., Giannarelli, D., Scambia, G. & Fagotti, A., 2024, In: Gynecologic Oncology. 187, X, p. 170-177 8 p.Research output: Contribution to journal › Article
Datasets
-
Supplementary Material for: Origin of residual tumor masses in BRCA1/2-driven ovarian carcinomas treated by neoadjuvant chemotherapy: selection of preexisting BRCA1/2-proficient tumor cells but not the gain of second ORF-restoring mutation
Sokolenko, A. (Contributor), Preobrazhenskaya, E. (Contributor), Marchetti, C. (Contributor), Piermattei, A. (Contributor), Zagrebin, F. (Contributor), Kuligina, E. (Contributor), Gorodnova, T. (Contributor), Pavone, M. (Contributor), Ivantsov, A. (Contributor), Bizin, I. (Contributor), Scambia, G. (Contributor), Berlev, I. (Contributor), Fagotti, A. (Contributor) & Imyanitov, E. (Contributor), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.23946975, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Origin_of_residual_tumor_masses_in_BRCA1_2-driven_ovarian_carcinomas_treated_by_neoadjuvant_chemotherapy_selection_of_preexisting_BRCA1_2-proficient_tumor_cells_but_not_the_gain_of_second_ORF-restoring_mutation/23946975
Dataset
-
Supplementary Material for: Origin of residual tumor masses in BRCA1/2-driven ovarian carcinomas treated by neoadjuvant chemotherapy: selection of preexisting BRCA1/2-proficient tumor cells but not the gain of second ORF-restoring mutation
Sokolenko, A. (Contributor), Preobrazhenskaya, E. (Contributor), Marchetti, C. (Contributor), Piermattei, A. (Contributor), Zagrebin, F. (Contributor), Kuligina, E. (Contributor), Gorodnova, T. (Contributor), Pavone, M. (Contributor), Ivantsov, A. (Contributor), Bizin, I. (Contributor), Scambia, G. (Contributor), Berlev, I. (Contributor) & Imyanitov, E. (Contributor), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.23939331.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Origin_of_residual_tumor_masses_in_BRCA1_2-driven_ovarian_carcinomas_treated_by_neoadjuvant_chemotherapy_selection_of_preexisting_BRCA1_2-proficient_tumor_cells_but_not_the_gain_of_second_ORF-restoring_mutation/23939331/1
Dataset
-
Upper-neck irradiation versus standard whole-neck irradiation in nasopharyngeal carcinoma: A systematic review and meta-analysis
De Felice, F. (Creator), Marchetti, C. (Creator), Serpone, M. (Creator), Camarda, A. (Creator), Vischioni, B. (Creator), Ingargiola, R. (Creator), Musio, D. (Creator) & Orlandi, E. (Creator), SAGE Journals, 2023
DOI: 10.25384/sage.c.6433771, https://sage.figshare.com/collections/Upper-neck_irradiation_versus_standard_whole-neck_irradiation_in_nasopharyngeal_carcinoma_A_systematic_review_and_meta-analysis/6433771
Dataset
-
Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients
Buttarelli, M. (Creator), Ciucci, A. (Creator), Palluzzi, F. (Creator), Raspaglio, G. (Creator), Marchetti, C. (Creator), Perrone, E. (Creator), Minucci, A. (Creator), Giacò, L. (Creator), Scambia, G. (Creator) & Gallo, D. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.c.5826914.v1, https://springernature.figshare.com/collections/Identification_of_a_novel_gene_signature_predicting_response_to_first-line_chemotherapy_in_BRCA_wild-type_high-grade_serous_ovarian_cancer_patients/5826914/1
Dataset
-
Additional file 2 of Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients
Buttarelli, M. (Creator), Ciucci, A. (Creator), Palluzzi, F. (Creator), Raspaglio, G. (Creator), Marchetti, C. (Creator), Perrone, E. (Creator), Minucci, A. (Creator), Giacò, L. (Creator), Scambia, G. (Creator) & Gallo, D. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.19126412.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Identification_of_a_novel_gene_signature_predicting_response_to_first-line_chemotherapy_in_BRCA_wild-type_high-grade_serous_ovarian_cancer_patients/19126412/1
Dataset